The domestic home medical device industry is in a development phase featuring standardized regulation and steady advancement of domestic substitution. Short-term traffic-oriented marketing cannot sustain long-term brand growth. Adhering to long-termism, and committing to in-depth product development and regulatory compliance represent the sustainable development path for medical device enterprises. Since its establishment, Hailes Biotech (Dandong) Co., Ltd. has rejected short-term profit-driven thinking. With long-term development plans covering R&D, manufacturing, distribution channels and public welfare, it steadily builds a trustworthy local brand for household blood glucose monitoring.

The primary pillar of its long-term development plan lies in continuous technological accumulation. The enterprise plans to expand its R&D laboratory scale year by year, increase investment in precision testing equipment, and enlarge its R&D teams for biological reagents and electronic hardware. It pursues sustained technological progress targeting portable home monitoring devices, long-term stable consumables and user-friendly operation. Multi-generation product upgrades will be completed in phases to enrich the portfolio of supporting home in-vitro monitoring products.

The second pillar concerns standardized upgrading of manufacturing. The company will continue expanding clean production workshops and introduce automated assembly and automatic testing production lines to reduce manual operational errors and enhance performance consistency of mass-produced goods. Meanwhile, it will upgrade the intelligent constant-temperature-and-humidity warehouse management system to realize automatic monitoring of storage temperature and humidity alongside automatic early warning for abnormalities, further refining full-process quality control standards.

The third pillar involves standardized nationwide channel layout. It pursues steady expansion of cooperative channels, avoiding blind growth and predatory low-price dumping that disrupt the market. The enterprise keeps improving the channel empowerment service system by providing support in compliant operation, warehouse management and after-sales training. It builds long-term stable partnerships with high-quality distributors nationwide and gradually expands coverage of offline retail outlets and primary medical institutions across the country.

The fourth pillar consists of regular public welfare health education. The company continuously collaborates with communities and local public welfare organizations to deliver science popularization on home health monitoring. It adheres to objective and compliant publicity to raise public awareness of standardized use of home monitoring devices, disseminate scientific home health management concepts, and fulfill the social responsibilities of a local enterprise.

Compliance serves as an enduring bottom line throughout all operations. All product upgrades, market promotion and publicity materials strictly comply with regulations governing medical devices. The company proactively cooperates with supervision and inspection by regulatory authorities, regularly updates internal compliance management systems, and prohibits short-term non-compliant marketing practices.

Taking long-termism as its core development philosophy, Hailes Biotech refrains from pursuing rapid short-term scale expansion. It focuses on refining product quality, optimizing service systems and operating in full compliance with regulations. The company will steadily enhance brand reputation as a domestic supplier of household blood glucose monitoring devices, and contribute sustained efforts from a local enterprise toward high-quality development of China’s home health monitoring industry.